ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Advancing Sight Network Receives $25,000 Grant from EyeSight Foundation of Alabama to Pursue Cures for Vision Loss

Advancing Sight Network, an Alabama-based nonprofit dedicated to preserving and restoring eyesight, has received a $25,000 grant from the EyeSight Foundation of Alabama and the Community Foundation of Greater Birmingham to support the organization’s new Cellular Research and Therapeutics Division.

The grant will fund specialized equipment to evaluate cells, a crucial step toward the goal of growing cells for drug development to treat eye diseases. In the long term, the program aims to develop transplantable therapies that could prevent vision loss for people worldwide.

“This equipment allows us to take a major step forward in our cell therapies program,” said Dr. Gregory Grossman, Chief Scientific Officer at Advancing Sight Network. “There is a lack of availability of human cell models for academic and industry researchers, and a growing need for cell-based transplantable therapies. We are incredibly grateful for the partnership with the EyeSight Foundation of Alabama and the Community Foundation of Greater Birmingham, which moves us closer to addressing those needs.”

Barbara Evers, Executive Director of the EyeSight Foundation of Alabama, emphasized the impact of the grant: “The EyeSight Foundation of Alabama is proud to support the purchase of equipment to enable Advancing Sight Network to provide high-quality, standardized cells for vision researchers in industry and academia, including at UAB (the University of Alabama at Birmingham). We are also hopeful the equipment will be helpful in developing additional transplantable therapies, which are desperately needed by people around the world.”

Grossman continued: “Approximately 90% of the vision loss in the world is preventable or treatable. But to get to a future where that reality is possible, we need to continue the critical research and work that grants like this enable. We look forward to contributing to work that helps create that future.”

Advancing Sight Network partners with leading research institutions, including UAB, to accelerate innovations in vision science and restore sight to those in need.

About Advancing Sight Network

Advancing Sight Network (ASN) is a mission-driven nonprofit dedicated to transforming lives and restoring sight. For more than 50 years, ASN has provided donated eye tissue for sight-restoring transplants and supported cutting-edge research to cure blinding eye diseases.

Based in Birmingham, Alabama, with a regional network across the southern U.S., ASN combines local focus with global vision in its mission to honor the gift of donation, advance eye-care innovation, and bring hope to individuals and communities affected by vision loss.

With nearly 100,000 tissues recovered for transplant, research and training, ASN’s work continues to move us closer to a world where vision loss is no longer inevitable.

For more information and to learn more about the work of Advancing Sight Network, visit advancingsight.org.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.